Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva...
-
Alvotech (NASDAQ: ALVO) og samstarfsaðili þess Teva Pharamceuticals, bandarískt dótturfélag Teva Pharmaceutical Industries Ltd. tilkynntu í dag að Matvæla- og lyfjastofnun Bandaríkjanna (FDA) hafi...
-
Stefnt er að því að birting árshluta- og ársuppgjörs Alvotech og aðalfundur félagsins fari fram sem hér segir á árinu 2025: Árshlutauppgjör fjórða ársfjórðungs 2024 og ársuppgjör 202426....
-
Addition is part of the annual reconstitution of the Nasdaq Biotech Index (NBI)Inclusion criteria include minimum market capitalization and daily trading volumes Alvotech (NASDAQ: ALVO), a global...
-
Alvotech verður hluti af NBI vísitölunni við opnun markaða í Bandaríkjunum 23. desember 2024 Alvotech (NASDAQ: ALVO) tilkynnti í dag að hlutabréf félagsins hafi verið tekin inn í Líftæknivísitölu...
-
Addition is part of the annual reconstitution of the Nasdaq Biotech Index (NBI)Inclusion criteria include minimum market capitalization and daily trading volumes REYKJAVIK, Iceland, Dec. 23, 2024 ...
-
Heildartekjur á fyrstu níu mánuðum ársins jukust um 300 milljónir dala frá sama tímabili árið 2023, í 339 milljónir dala, þar af voru tekjur 103 milljónir dala á þriðja ársfjórðungi Tekjur af vörusölu...
-
Total Revenues in the first nine months of 2024 increased by $300 million compared to same period in 2023, to $339 million, with Q3 revenues contributing $103 millionProduct revenues in the first nine...
-
Total Revenues in the first nine months of 2024 increased by $300 million compared to same period in 2023, to $339 million, with Q3 revenues contributing $103 millionProduct revenues in the first nine...
-
REYKJAVIK, Iceland, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...